EUVIMEDEUVIMED entdecken
Crossref

TRIB3 promotes lipid accumulation and lipogenesis in esophageal cancer progression

Hongye Zhao, Longyu Zhu, Kun Wu, Zhaolong Zhao, Jingge Cheng, Yishuai Li

Cellular Signalling · 2026

DOI: 10.1016/j.cellsig.2026.112805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Hongye Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, PR China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Lipogenesis, Cell Cycle Proteins, Lipid Metabolism. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Hebei Province Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Esophageal cancer is a malignant tumor with extremely poor prognosis. Its developmental mechanisms remain incompletely elucidated. Altered lipogenesis plays a crucial role in tumor progression. However, the specific mechanisms by which TRIB3 regulates lipid accumulation in esophageal cancer remain unclear. This study aims to investigate how TRIB3-ATF4 interaction influences lipogenic enzyme expression and tumor progression through the ERK1/2 pathway in esophageal cancer. METHODS: This study employed the esophageal cancer cell lines (TE5 and KYSE150) as a research model. We performed TRIB3 overexpression, knockdown, and ATF4 interaction analyses. These were combined with molecular biology techniques and functional assays (EdU, colony formation, migration, and invasion). Pharmacological inhibitors of ERK and FASN, alongside oleic acid (OA) rescue, validated the signaling and metabolic pathways. RESULTS: TRIB3 regulates fatty acid metabolism. TRIB3 knockdown suppresses fatty acid biosynthesis, cell growth, and migration. Mechanistically, TRIB3 interacts with ATF4 to activate the MEK/ERK pathway. FASN inhibition reverses TRIB3's oncogenic effects. Conversely, OA rescues the tumor-suppressive phenotypes of TRIB3 knockdown. Inhibition of the MEK/ERK pathway attenuates TRIB3-mediated lipid metabolism and progression. CONCLUSION: This study identifies TRIB3 as a key metabolic regulator in esophageal cancer. It links stress adaptation to lipogenic reprogramming. Targeting this metabolic vulnerability represents a promising therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsLipogenesisCell Cycle ProteinsLipid MetabolismProtein Serine-Threonine KinasesRepressor ProteinsHumansCell Line, TumorActivating Transcription Factor 4Disease ProgressionCell MovementCell ProliferationMAP Kinase Signaling SystemFatty Acid Synthase, Type I

Stichwörter der Autor:innen

ATF4ERK1/2 pathwayEsophageal cancerLipid metabolism reprogrammingTRIB3

Substanzen

TRIB3 protein, humanCell Cycle ProteinsActivating Transcription Factor 4Protein Serine-Threonine KinasesRepressor ProteinsATF4 protein, humanFatty Acid Synthase, Type IFASN protein, human

Autor:innen und Institutionen

  • Department of Dermatology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, PR China.
  • Department of Dermatology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, PR China; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, PR China.
  • Department of Anesthesiology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, PR China.
  • Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, PR China. Electronic address: 48801754@hebmu.edu.cn.
  • Department of Thoracic Surgery, Hebei Provincial Key Laboratory of Pulmonary Disease, Hebei Chest Hospital, Shijiazhuang 050041, PR China. Electronic address: liyishuai66@126.com.

Förderung

  • Hebei Province Health Commission

Zitieren

APA

Zhao, H., Zhu, L., Wu, K., Zhao, Z., Cheng, J., & Li, Y. (2026). TRIB3 promotes lipid accumulation and lipogenesis in esophageal cancer progression. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112805

Vancouver

Zhao H, Zhu L, Wu K, Zhao Z, Cheng J, Li Y. TRIB3 promotes lipid accumulation and lipogenesis in esophageal cancer progression. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112805

BibTeX
@article{Zhao2026,
  author = {Zhao, Hongye and Zhu, Longyu and Wu, Kun and Zhao, Zhaolong and Cheng, Jingge and Li, Yishuai},
  title = {TRIB3 promotes lipid accumulation and lipogenesis in esophageal cancer progression},
  journal = {Cellular Signalling},
  year = {2026},
  doi = {10.1016/j.cellsig.2026.112805}
}
Kostenlos starten →